Microsomal prostaglandin E synthase is regulated by proinflammatory cytokines and glucocorticoids in primary rheumatoid synovial cells

被引:240
作者
Stichtenoth, DO
Thorén, S
Bian, HM
Peters-Golden, M
Jakobsson, PJ
Crofford, LJ
机构
[1] Univ Michigan, Div Rheumatol, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Div Pulm & Crit Care Med, Ann Arbor, MI 48109 USA
[3] Karolinska Inst, MBB, Div Chem 2, Stockholm, Sweden
关键词
D O I
10.4049/jimmunol.167.1.469
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The selective induction of PGE(2) synthesis in inflammation suggests that a PGE synthase may be linked to an inducible pathway for PG synthesis. We examined the expression of the recently cloned inducible microsomal PGE synthase (mPGES) in synoviocytes from patients with rheumatoid arthritis, its modulation by cytokines and dexamethasone, and its linkage to the inducible cyclooxygenase-2. Northern blot analysis showed that IL-1 beta or TNF-alpha treatment induces mPGES mRNA from very low levels at baseline to maximum levels at 24 h. IL-1 beta -induced mPGES mRNA was inhibited by dexamethasone in a dose-dependent fashion. Western blot analysis demonstrated that mPGES protein was induced by IL-1 beta, and maximum expression was sustained for up to 72 h. There was a coordinated up-regulation of cyclooxygenase-2 protein, although peak expression was earlier. Differential Western blot analysis of the microsomal and the cytosolic fractions revealed that the induced expression of mPGES protein was limited to the microsomal fraction. The detected mPGES protein was catalytically functional as indicated by a Mold increase of PGES activity in synoviocytes following treatment with IL-1 beta; this increased synthase activity was limited to the microsomal fraction. In summary, these data demonstrate an induction of mPGES in rheumatoid synoviocytes by proinflammatory cytokines. This novel pathway may be a target for therapeutic intervention for patients with arthritis. The Journal of Immunology, 2001.
引用
收藏
页码:469 / 474
页数:6
相关论文
共 40 条
[1]  
Alaaeddine N, 1999, ARTHRITIS RHEUM-US, V42, P710, DOI 10.1002/1529-0131(199904)42:4<710::AID-ANR14>3.0.CO
[2]  
2-4
[3]   Cyclooxygenase-2 up-regulation after FLAP transfection in human adenocarcinoma cell line HT29 cl.19A [J].
Battu, S ;
Beneytout, JL ;
Pairet, M ;
Rigaud, M .
FEBS LETTERS, 1998, 437 (1-2) :49-55
[4]   INDUCTION OF VASCULAR ENDOTHELIAL GROWTH-FACTOR EXPRESSION IN SYNOVIAL FIBROBLASTS BY PROSTAGLANDIN-E AND INTERLEUKIN-1 - A POTENTIAL MECHANISM FOR INFLAMMATORY ANGIOGENESIS [J].
BENAV, P ;
CROFFORD, LJ ;
WILDER, RL ;
HLA, T .
FEBS LETTERS, 1995, 372 (01) :83-87
[5]   Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. [J].
Bombardier, C ;
Laine, L ;
Reicin, A ;
Shapiro, D ;
Burgos-Vargas, R ;
Davis, B ;
Day, R ;
Ferraz, MB ;
Hawkey, CJ ;
Hochberg, MC ;
Kvien, TK ;
Schnitzer, TJ ;
Weaver, A .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (21) :1520-1528
[6]  
Catella-Lawson F, 1999, J PHARMACOL EXP THER, V289, P735
[7]  
Crofford LJ, 2000, ARTHRITIS RHEUM, V43, P1891, DOI 10.1002/1529-0131(200008)43:8<1891::AID-ANR28>3.0.CO
[8]  
2-R
[9]   CYCLOOXYGENASE-1 AND CYCLOOXYGENASE-2 EXPRESSION IN RHEUMATOID SYNOVIAL TISSUES - EFFECTS OF INTERLEUKIN-1-BETA, PHORBOL ESTER, AND CORTICOSTEROIDS [J].
CROFFORD, LJ ;
WILDER, RL ;
RISTIMAKI, AP ;
SANO, H ;
REMMERS, EF ;
EPPS, HR ;
HLA, T .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (03) :1095-1101
[10]  
Crofford LJ, 2000, ARTHRITIS RHEUM-US, V43, P4, DOI 10.1002/1529-0131(200001)43:1<4::AID-ANR2>3.0.CO